Whole-Body Vibration Versus Neuro Muscular Electrical Stimulation on Patients With ICU Acquired Weakness
NCT07336810
Intensive Care (ICU), Intensive Care (ICU) Myopathy
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT Number: NCT02911896
Impairment in physical function is a significant problem for survivors of critical illness. There is a growing urgency to develop a core set of outcome measures, which can be adopted in clinical and research practice to evaluate efficacy in response to interventions such as rehabilitation.
Phase 1: Development of a new outcome measure. This study aims to examine the development of a single outcome measure which may be able to be utilised across the continuum of recovery of critical illness in the evaluation of physical function. The study will involve examination of two common physical function measures - the Physical Function in intensive care test scored (PFIT-s) and De Morton Mobility Index (DEMMI) and the development of a new measure based on rasch principles which may be able to capture physical functioning changes in individuals with critical illness. Aims: (1) To determine the clinical utility of two physical function measures (DEMMI and PFIT-s) when used in isolation across the hospital admission; and (2) To transform the (15-item) DEMMI and (4-item) PFIT-s into a single measure to evaluate function in intensive care survivors using Rasch analytical principles.
Phase 2: Measurement properties of the PACIFIC physical function outcome measure in an independent validation sample.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University of South Australia and Flinders Medical Centre, Adelaide, South Australia, Australia
Consecutive eligible patients will be recruited into the study.
Phase 1: Two outcome measures - PFIT-s and DEMMI will be performed within 24 hour period. Order of testing will be randomised to minimise testing bias. Time-points of assessment are: awakening, ICU discharge and hospital discharge. Weekly measures will also be performed if required in ICU and/or ward settings for up to a maximum of 30 days in each setting. The measurement properties of the individual tools PFIT-s and DEMMI will be examined (e.g. validity, responsiveness).
Phase 2: Based on the findings in Phase 1 a new single outcome measure will be developed. In the second phase examination of the measurement properties of the tool will be undertaken including (reliability, validity, responsiveness).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline to hospital discharge (up to 3 months)
Both measures are primary - there will be a single measure developed as composite in line with aims of this observational study
University of Melbourne
Other
Physical Function in Critical Care (PaciFIC): An Multi-centre Observational Study
Acronym: PaciFIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07336810
Intensive Care (ICU), Intensive Care (ICU) Myopathy
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT03714399
Aortic Diseases, Cardiovascular Diseases
London, United Kingdom
View Trial DetailsNCT05282576
Intensive Care (ICU) Myopathy, Intensive Care Unit Acquired Weakness
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03547687
Intensive Care (ICU) Myopathy, Muscular Diseases
Portland, Oregon, United States
View Trial Details